Interesting. Thanks for sharing your insights and

New Post Public Reply Private Reply Replies (0) Message Board
EliteYoda Floatable1 #11437

Interesting. Thanks for sharing your insights and perspective, Floatable.

In my opinion, the audited financials and the 10K should have been made public back during the November elections when the MJ laws were changing nationwide and there was a lot of excitement in the investor community. Back when all that was happening, nothing happened for RFMK, except promises about big things coming "soon". These "imminent" accomplishments never came, so as an interested RFMK follower, I personally am of the opinion that it may be better to wait and see what the CEO delivers (or not) before coming to a consensus as to the efficacy of his work. At this point, I will believe it when I see it.

Though I do agree with you that with the stock at all time lows and with practically zero volume except for maybe a few market playas doing their thing supposedly "providing liquidity", it may indeed be a great time to get in; perhaps at these prices there is an opportunity. IMO it could be an opportunity only if the CEO is in fact working diligently on actually realizing certain corporate accomplishments. The issue, of course, is that we, the investing public, really have no way of knowing what is going on behind the scenes. He could very well be wrapping up a long arduous audit process and it's nearly done and he could be submitting filings very very soon, OR, it could all just be a lot of hot air, to instigate excitement over the stock so investors buy up the shares the company is selling so the money raised (after months of massive dilution) can be handed over to sketchy insiders. As a long term investor (not a trader in PK stocks), I always remain hopeful that management can do the right thing and bring real shareholder value by way of actualized corporate progress. He may still very well come through for shareholders! And for me personally that will be a major BUY signal on a fundamental basis because the CEO would have then restored management credibility from my perspective. I think much credibility was destroyed with the last filing which effectively showed the CEO handing over half a million dollars to B. Fouch for some unknown reason. IMO such dealings behind the scenes need to be fully explained by the CEO to shareholders. Clarity and transparency are not bonuses, they are absolute requirements for investors to be able to feel confident of that in which they invest their hard earned dollars. At different share prices, I naturally become a bull, a bear or agnostic, depending on what is currently the status of the fundamental story. At 40% to 30% below par value for the stock, I must say, it is rather difficult to feel bearish of RFMK stock, no matter what is going on. I think it is now "make or break" for this company "story". Either the CEO comes through for shareholders or he does not. It's that simple. IMO those on other boards beating a dead horse 24/7 are wasting a lot of time in their lives. Some boards have become a cesspool of hatred and nonsense squawking of mindless banter between obvious manipulators of sentiment and it's made up mostly of 24/7 bashers and haters. I would not be surprised if most of the talking heads are paid bashers for firms massively short this stock. All must do their own DD and make their own buy/hold/sell decisions. IMO to always be only a bear at any price is ridiculous (so long as the company is not actually a PK scam), and to always be only a bull at any price is also mindless. Investors must know their own financial situations and learn to have levels associated with certain fundamental analysis such that the investor becomes a bull, a bear or agnostic at particular share prices.

May the force be with us.

GLTA

$RFMK

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PolyBio Convergence Summit Tackles Aging, Chronic Illness

Updated Category News Views 146

Kicking Off The Convergence: Pathogens in Focus Here's a gathering that's set to challenge how we think about lingering illnesses and aging. PolyBio Research Foundation is bringing a powerhouse of brains to the table with their inaugural Convergence Summit. It's more than just science talk; it's a chance to push boundaries in understanding how pathogens stick around and...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 69

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 142

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 155

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 87

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 71

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Thread AI Joins Microsoft Pegasus: Big AI Leap

Updated Category News Views 26

Thread AI Leaps Ahead with Microsoft Partnership There's excitement in the air as Thread AI joins forces with Microsoft by entering the exclusive Pegasus Program. In the ever-evolving world of AI, making a splash this big doesn't happen every day. People in the tech alley are buzzing, and it looks like Thread AI is ready to rumble on a larger stage—much like a scrappy...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 85

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 67

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 135

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading

Top 5 Most Recently Viewed Articles

Conagra Brands: Navigating Challenges with Strong Dividends and Growth

Updated Category News Views 164

Conagra's Market Position and Opportunities Conagra Brands Inc (NYSE: CAG) shares are currently experiencing a significant dip, providing a favorable opportunity for long-term investors to consider entry into the market. Despite the ongoing challenges that are affecting the consumer staples sector, Conagra has ended its recent business contraction. The company's...

Continue Reading
Unlocking the Potential of AeroVironment Stock Investments

Updated Category News Views 215

The Growth Journey of AeroVironment (NASDAQ: AVAV) AeroVironment continues to impress investors with its steady performance over recent years. This aerospace company specializes in drone technology and has showcased remarkable growth potential in a competitive industry. Despite the challenges posed by changing market conditions, AeroVironment has outperformed the market...

Continue Reading
Focal One® Robotic HIFU Shows Promise in Prostate Cancer Care

Updated Category News Views 131

Groundbreaking Results from the HIFI Study The HIFI Study stands as a significant milestone in the treatment of localized prostate cancer, presenting remarkable findings and setting the stage for a shift in medical practices. This extensive research, with a participant group of 3,328, compares HIFU treatment using Focal One® against traditional surgery methods,...

Continue Reading
VENU's Ambitious Growth Strategy Secures $34.5 Million Funding

Updated Category News Views 307

VENU Secures Funding to Propel Its Growth Strategy In recent news, VENU (NYSE American: VENU), a company leading the charge in premium hospitality and live entertainment, has successfully closed a public offering. This offering involved 2,875,000 shares of common stock, sold at a public price of $12.00 each, bringing in $34.5 million in gross proceeds. This substantial...

Continue Reading
Exploring Market Trends in the Food Colors Industry

Updated Category News Views 250

The food colors market saw a hefty rise, hitting projections of USD 6.0 billion by 2028 from USD 4.6 billion in 2023. This growth came at a compound annual growth rate (CAGR) of about 5.4%, thanks to shifting consumer preferences towards naturally sourced and visually appealing products. Market Dynamics: The Push for Natural Colors Back then, the processed food scene was...

Continue Reading